blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1749013

EP1749013 - STABLE AMORPHOUS CEFDINIR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.04.2010
Database last updated on 02.11.2024
Most recent event   Tooltip09.04.2010Application deemed to be withdrawnpublished on 12.05.2010  [2010/19]
Applicant(s)For all designated states
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064-3500 / US
[N/P]
Former [2008/36]For all designated states
ABBOTT LABORATORIES
CHAD 0377/AP6A-1 100 Abbott Park Road
Abbott Park IL 60064-3500 / US
Former [2007/06]For all designated states
ABBOTT LABORATORIES
Dept. 377 Bldg. AP6A-1, 100 Abbott Park Road
Abbott Park, Illinois 60064-6008 / US
Inventor(s)01 / SERVER, Nancy, E.
2643 N. Drury Lane
Arlington Heights, IL 60004 / US
02 / LAW, Devalina
944 S. Fourth Avenue
Libertyville, IL 60048 / US
 [2007/06]
Representative(s)Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd
Thierschstrasse 11
80538 München / DE
[N/P]
Former [2009/36]Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11
80538 München / DE
Former [2007/06]Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11
80538 München / DE
Application number, filing date05735632.111.04.2005
[2007/06]
WO2005US12439
Priority number, dateUS2004082169509.04.2004         Original published format: US 821695
[2007/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005100368
Date:27.10.2005
Language:EN
[2005/43]
Type: A2 Application without search report 
No.:EP1749013
Date:07.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 27.10.2005 takes the place of the publication of the European patent application.
[2007/06]
Search report(s)International search report - published on:EP24.08.2006
ClassificationIPC:C07D501/00
[2007/06]
CPC:
C07D501/00 (EP,US); A61P31/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/06]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:STABILES AMORPHES CEFDINIR[2007/06]
English:STABLE AMORPHOUS CEFDINIR[2007/06]
French:CEFDINIR AMORPHE STABLE[2007/06]
Entry into regional phase08.11.2006National basic fee paid 
08.11.2006Designation fee(s) paid 
08.11.2006Examination fee paid 
Examination procedure08.11.2006Amendment by applicant (claims and/or description)
08.11.2006Examination requested  [2007/06]
03.11.2009Application deemed to be withdrawn, date of legal effect  [2010/19]
11.12.2009Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2010/19]
Fees paidRenewal fee
10.04.2007Renewal fee patent year 03
18.03.2008Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.200905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DY]US4559334  (TAKAYA TAKAO [JP], et al) [DY] 4,8,9,13,14 * column 11, line 67 - column 12, line 5 *;
 [Y]EP0404558  (YISSUM RES DEV CO [IL], et al) [Y] 4-8,11-13 * page 6, lines 31-36; claims 1,3 ** page 9, lines 8-12 *;
 [Y]EP0890359  (FUJISAWA PHARMACEUTICAL CO [JP]) [Y] 4,8-10,13 * example 8; claims 1,7; table 9 *;
 [Y]US2002142040  (NOMURA MASAAKI [JP], et al) [Y] 4-13 * paragraphs [0001] , [0015] , [0018] - [0021] *;
 [XY]WO2004046154  (ORCHID CHEMICALS & PHARM LTD [IN], et al) [X] 1-3 * page 5, lines 18-25; figure 1/1; examples 1-4; claim 9 * * page 10, line 14 - page 11, line 5 * [Y] 4-14;
 [Y]US2005059819  (DUERST RICHARD W [US], et al) [Y] 4,8-10,13,14 * paragraphs [0021] , [0023] *;
 [Y]  - OMNICEF (CEFDINIR) CAPSULES - OMNICEF (CEFDINIR) FOR ORAL SUSPENSION, (200009), XP002328280 [Y] 4,9,11,13 * page 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.